InsidersTradesSigma
Total declarations
Company
▲ Purchases (23 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
23
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+20.2%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Jones James, Director. Director active across 1 company, notably Cumberland Pharmaceuticals INC. In total, 43 reports have been published. Breakdown: 23 buys · 0 sell. Total volume traded: €2k. History available since 17 March 2021. The latest transaction was disclosed on 18 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Jones James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations43 total
1,800 shares@ US$2.8018.3% of flowCommon StockSEC:0001087294-26-000039:0
18 shares@ US$2.360.2% of flowCommon StockSEC:0001087294-26-000006:0
13 shares@ US$2.800.1% of flowCommon StockSEC:0001490829-25-000007:0
13 shares@ US$3.310.2% of flowCommon StockSEC:0001490829-25-000005:0
12 shares@ US$3.540.2% of flowCommon StockSEC:0001087294-25-000008:0
13 shares@ US$3.440.2% of flowCommon StockSEC:0001628280-25-041987:0
Canonical exit: 30 Oct 2025 (T+90)
16 shares@ US$3.560.2% of flowCommon StockSEC:0001628280-25-039404:0
Canonical exit: 29 Sept 2025 (T+90)
8 shares@ US$5.200.2% of flowCommon StockSEC:0001628280-25-034816:0
Canonical exit: 31 Aug 2025 (T+90)
8 shares@ US$4.860.2% of flowCommon StockSEC:0001628280-25-029854:0
Canonical exit: 30 Jul 2025 (T+90)
8 shares@ US$4.240.1% of flowCommon StockSEC:0001628280-25-024353:0
Canonical exit: 30 Jun 2025 (T+90)
10 shares@ US$5.540.2% of flowCommon StockSEC:0001628280-25-016743:0
Canonical exit: 1 Jun 2025 (T+90)
1,000 shares@ US$5.1720.9% of flowCommon StockSEC:0001628280-25-013544:0
2,500 shares@ US$1.7117.4% of flowCommon StockSEC:0001628280-25-003184:0
70 shares@ US$1.330.4% of flowCommon StockSEC:0001628280-24-052608:0
Canonical exit: 2 Mar 2025 (T+90)
76 shares@ US$1.150.4% of flowCommon StockSEC:0001628280-24-050111:0
Canonical exit: 30 Jan 2025 (T+90)
62 shares@ US$1.270.3% of flowCommon StockSEC:0001628280-24-045331:0
Canonical exit: 30 Dec 2024 (T+90)
50 shares@ US$1.380.3% of flowCommon StockSEC:0001628280-24-042120:0
44 shares@ US$1.470.3% of flowCommon StockSEC:0001214659-24-016020:0
44 shares@ US$1.470.3% of flowCommon StockSEC:0001214659-24-013687:0
25 shares@ US$1.520.2% of flowCommon StockSEC:0001214659-24-011869:0
1,000 shares@ US$1.717.0% of flowCommon StockSEC:0001214659-24-005224:0
72 shares@ US$1.690.5% of flowCommon StockSEC:0001214659-23-017035:0
55 shares@ US$1.850.4% of flowCommon StockSEC:0001214659-23-016101:0
55 shares@ US$1.890.4% of flowCommon StockSEC:0001214659-23-014542:0
65 shares@ US$1.680.4% of flowCommon StockSEC:0001214659-23-013094:0
25 of 43 declarations
About Jones James
Jones James is Administrateur at Cumberland Pharmaceuticals INC (XNAS). He has 43 filings in total, and across the 43 sampled filings, the aggregate buy amount is EUR 1666 and the aggregate sell amount is EUR 0, with filings ranging from 2021-06-11 to 2026-03-20 and a modal transaction nature indicated as Acquisition.
